pyrazolanthrone has been researched along with Polycystic Ovarian Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, Y; He, Y; Li, J; Li, X; Lu, Y; Qi, J; Sun, Y; Wang, W; Wang, Y; Wu, H; Xu, R; Zhu, Q; Zhu, Z | 1 |
| Bulut, G; Dönmez, YB; Erten, R; Kurdoglu, M; Kurdoglu, Z | 1 |
2 other study(ies) available for pyrazolanthrone and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
Novel role of CXCL14 in modulating STAR expression in luteinized granulosa cells: implication for progesterone synthesis in PCOS patients.
Topics: Adult; Anthracenes; Cells, Cultured; Chemokines, CXC; Cholesterol Side-Chain Cleavage Enzyme; Cyclic AMP Response Element-Binding Protein; Enzyme Inhibitors; Female; Flavonoids; Gene Expression Regulation; Granulosa Cells; Humans; Imidazoles; Phosphoproteins; Polycystic Ovary Syndrome; Progesterone; Progesterone Reductase; Pyridines | 2021 |
Effects of jnk inhibitor on inflammation and fibrosis in the ovary tissue of a rat model of polycystic ovary syndrome.
Topics: Animals; Anthracenes; Disease Models, Animal; Female; Fibrosis; Immunohistochemistry; Inflammation; MAP Kinase Kinase 4; Polycystic Ovary Syndrome; Protein Kinase Inhibitors; Rats; Rats, Wistar | 2015 |